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1 SUMMARY 
Bacteria belonging to the genus Mycoplasma occur worldwide in human beings as well as in 
a wide range of animals. A rather specialized group within the genus Mycoplasma consists of 
the so-called hemotrophic mycoplasmas (HMs) which are characterized by strict host 
specificity and uncultivability in vitro. This uncultivable state of HMs is a major problem and 
makes research a challenging task. HMs are pleomorphic bacteria which attach to the 
surface of red blood cells (RBCs) or also invade RBCs. Attachment as well as invasion can 
lead to cell deformation as well as to apoptosis of the target cells. However, the close contact 
between the host cell and the bacteria also seems to be essential for the specialized life 
cycle of HMs.  
Mycoplasma suis a representing member of the HM-group induces infectious anemia in pigs 
(IAP). The disease is characterized by two different courses, i.e. acute infection vs. chronic 
infection. Especially the chronic form can cause substantial economic losses in swine 
production and therefore, has to be characterized in detail.  
In contrast to the acute form of IAP which can be investigated by the aid of a splenectomized 
pig infection model, there is no established pig infection model which can be used for the 
analysis of the chronic IAP. 
M. suis is connected to the surface of erythrocytes by fibrillary structures. The exact 
mechanism of adhesion is quite unclear up to now. Nevertheless, three surface proteins with 
adhesion properties (HspA1, MSG1, and α-enolase) have been investigated in detail so far. 
Their corresponding genes as well as recombinant gene products are used for diagnostic 
purposes of M. suis in clinical samples (PCR, serology). Currently, the most efficient 
diagnostic test is the real-time polymerase chain reaction (Rt-PCR). It enables the diagnosis 
of chronic as well as acute IAPs which are characterized by low or high bacterial loads, 
respectively.  
Clinical signs of both forms can be cured by the application of tetracycline, iron dextran and 
glucose. However, the elimination of M. suis from infected hosts is not possible yet. 
Therefore, once infected animals act as carriers and transmitters of M. suis within and 
between herds. Nevertheless, detailed investigations on specific transmission pathways in 
acute as well as in chronic M. suis infections are quite rare.  
 
The aims of this work were to establish a chronic pig infection model and to clarify 
unrecognized transmission pathways of M. suis. In addition, proteomics-based investigations 
of M. suis should be performed to improve the knowledge on the host pathogen interactions 
and host adaptation in IAP. 
Based on the succeeded and frequently applied splenectomized M. suis pig model (acute 
infection model) it was possible to establish a novel non-splenectomized M. suis pig model. 
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This infection model enables the experimental investigation of the chronic M. suis infection. 
To this end, the piglets were infected intramuscularly with a highly virulent M. suis strain. 
Infected animals exhibited clinical signs (e.g. Morbus maculosus) including the typical cyclic 
course of chronic IAP.  
In the next step, potential transmission pathways of M. suis were analyzed during acute and 
chronic M. suis infection based on these two pig infection models. Feces, urine, air and dust 
as well as nasal, vaginal and saliva excretions were collected during the course of infection 
and examined for M. suis DNA by Rt-PCR. For the first time it was possible to detect M. suis 
in urine with and without erythrocytes as well as in nasal, vaginal and saliva excretions 
during acute and chronic infections. These results indicate blood-independent M. suis 
transmission via vaginal discharge, nasal excretions, saliva, and urine.  
The non-culturability limited the improvement of proteomic-based investigations of M. suis-
related host-pathogen interactions. Therefore, we used modern and sophisticated proteome 
analysis to solve this problem. Blood samples from experimentally infected pigs at different 
time points of infection were investigated. For this, novel enrichment methods for M. suis 
proteins (especially membrane proteins) were established. These methods enabled an 
improved resolution of the protein expression profile of M. suis and thereby deeper insights 
into the pathogenesis of this microorganism. Despite of the missing cultivation system it was 
possible to identify more than 50% of the predicted M. suis proteins during acute infection. 
This identification ratio is similar to the one found in cultivable bacteria. Furthermore, the 
results of the proteome analysis indicate that nutrients such as glucose, hexose-6-
phosphate, spermidine, putrescine, phosphate, amino acids, magnesium, potassium, sodium 
and iron are taken up by M. suis from the host leading to the high degree of host adaptation. 
Therefore, gained information on expressed M. suis proteins involved in transport are helpful 
in the establishment of an in vitro cultivation system in future. Particularly the 
supplementation of individual nutrients can play key functions in the media to support growth. 
Besides the M. suis proteome the acquired dataset firstly enables also the quantitative 
identification of Sus scrofa proteins differentially expressed during M. suis infection. This 
information can be used to unravel infection-relevant processes in the host in further studies. 
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2 ZUSAMMENFASSUNG 
Bakterien der Gattung Mycoplasma treten sowohl bei Menschen als auch bei einer Vielzahl 
von Tieren auf. Eine hoch-spezialisierte Gruppe von Bakterien innerhalb der Gattung 
Mycoplasma sind die sogenannten haemotrophen Mycoplasmen (HM). Diese sind durch 
eine hohe Wirtsspezifität charakterisiert und können nicht unter Laborbedingungen kultiviert 
werden. Das Fehlen eines in vitro-Kultursystems erschwert die Erforschung der HM 
wesentlich. HM sind pleomorphe Bakterien, welche an die Oberfläche von Erythrozyten 
binden oder in diese eindringen. Sowohl die Anlagerung als auch die Invasion kann zu 
Deformationen bzw. zur Apoptose des Erythrozyten führen. Zudem scheint der enge Kontakt 
zwischen Wirtszelle und Bakterien für die Lebensfähigkeit der HM essentiell zu sein.  
Mycoplasma suis ist ein Vertreter der HM-Gruppe, der bei Schweinen die sogenannte 
infektiöse Anämie (IAP) verursacht. Diese Krankheit ist sowohl durch eine akute als auch 
eine chronische Verlaufsform gekennzeichnet. Die akute Verlaufsform konnte anhand des 
splenektomierten M. suis-Models bereits sehr gut charakterisiert werden. Im Vergleich dazu 
existiert jedoch kein Infektionsmodel für die Analyse der chronischen Form der Anämie. 
Gerade diese führt jedoch zu hohen ökonomischen Verlusten in den Schweinebetrieben, 
deshalb ist eine genaue Charakterisierung dringend erforderlich. 
Die Anlagerung von M. suis an die Oberfläche der Schweinerythrozyten findet mit Hilfe von 
fibrillären Strukturen statt. Der genaue Mechanismus ist derzeit noch nicht geklärt. Dennoch 
gelang es bereits, drei Oberflächenproteine (HspA1, MSG1 und α-enolase) mit 
Adhäsionseigenschaften zu identifizieren und im Detail zu untersuchen. Die 
korrespondierenden Gene und rekombinanten Genprodukte dienen dem diagnostischen 
Nachweis von M. suis in klinischen Proben (PCR, Serologie). Die derzeit effektivste Methode 
stellt hierbei die Echtzeit-Polymerasekettenreaktion (Rt-PCR) dar. Die Rt-PCR ermöglicht es, 
sowohl die chronische Verlaufsform mit geringen Bakterienzahlen als auch die akute 
Verlaufsform mit hohen Bakterienzahlen im Blut zu detektieren. Die auftretenden 
Krankheitssymptome beider Formen werden mithilfe von Tetrazyklin, Eisendextran und 
Glukose behandelt. Eine vollständige Eliminierung von M. suis aus dem Wirt wird hierbei 
jedoch nicht erreicht. Dies führt dazu, dass einmal infizierte Tiere lebenslang als Träger und 
Überträger von M. suis innerhalb und zwischen den Herden fungieren. Die genauen 
Übertragungswege von M. suis konnten bislang weder für die akute noch für die chronische 
Verlaufsform im Detail geklärt werden.  
 
Ziele dieser Arbeit waren, ein Infektionsmodel im Schwein zu etablieren, dass den 
chronischen Verlauf der IAP darstellt, bisher unerkannte potenzielle Übertragungswege zu 
identifizieren und abschließend anhand Proteom-basierter Untersuchungen M. suis-
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spezifische Wirts-Pathogen Interaktionen sowie die Wirtsabhängigkeit genauer zu 
untersuchen. 
Als Ergänzung zu dem bereits sehr häufig erfolgreich verwendeten Schweinemodel (mit 
Splenektomie), dass die akute Verlaufsform einer natürlichen IAP widerspiegelt, gelang es 
uns ein neues Schweinemodel zu etablieren, dass die detaillierte Untersuchung von 
chronisch verlaufenden, phasenweise klinisch inapparenten M. suis-Infektionen erlaubt. 
Hierfür werden Ferkel ohne vorhergehende Splenektomie intramuskulär mit einem hoch-
virulenten M. suis Stamm infiziert. Bei den experimentell infizierten Ferkeln konnte neben 
Symptomen einer chronischen IAP (z.B. Morbus maculosus) auch der typische zyklische 
Verlauf der chronischen M. suis-Infektion beobachtet werden. Unter Verwendung der beiden 
beschriebenen Infektionsmodelle wurden potenzielle Übertagungswege von M. suis während 
der akuten bzw. der chronischen Verlaufsform der IAP untersucht. Dazu wurde von den 
experimentell infizierten Schweinen Kot, Harn, Nasen-, Vaginal- und Speichelsekret sowie 
Proben aus der Umgebung der Tiere (Wasser, Luft und Staub) gesammelt und mittels Rt-
PCR auf die Anwesenheit von M. suis-DNA analysiert. Die Studien zeigten erstmals, dass 
M. suis offensichtlich sowohl über Harn (mit und ohne Erythrozyten) als auch über Nasen-, 
Vaginal- und Speichelsekret während der chronischen und der akuten Verlaufsform der 
Krankheit ausgeschieden wird. Somit ist klar, dass die Übertragung von M. suis Blut 
unabhängig über Körpersekrete und Harn möglich ist. Die Erforschung der Wirt-Pathogen 
Interaktionen und der spezifischen Anpassung von M. suis an seinen Wirt ist durch den 
nicht-kultivierbaren Status des Erregers limitiert. Um diese Probleme zu lösen, wurden 
moderne und hochentwickelte Proteomanalysen durchgeführt. Als Untersuchungsmaterial 
dienten Blutproben experimentell infizierter Schweine aus unterschiedlichen 
Infektionsstadien. Anhand dieser Proben gelang es, eine Anreicherungsmethode für M. suis 
Proteine (insbesondere Membranproteine) zu etablieren. Diese ermöglicht eine verbesserte 
Auflösung des Proteinexpressionsmusters von M. suis und gewährleistet tiefere Einblicke in 
dessen Pathogenese. So konnten trotz der Unkultivierbarkeit des Erregers ca. 50% der 
vorhergesagten M. suis-Proteine während einer akuten Phase der Infektion detektiert 
werden. Diese Proteinexpressionsdaten von M. suis sind aufgrund ihrer hohen Auflösung 
erstmals mit Proteomanalysen von kultivierbaren Bakterien vergleichbar. Des Weiteren 
zeigten die gewonnenen Daten, dass Nährstoffe wie Glukose, Hexose-6-Phosphat, 
Spermidin, Phosphat, Aminosäuren, Magnesium, Kalium, Natrium und Eisen, während einer 
M. suis-Infektion aus der Wirtsumgebung von M. suis aufgenommen werden. Die 
gewonnenen Erkenntnisse über die exprimierten potenziellen M. suis-Transportersysteme 
spielen insbesondere für die Entwicklung eines in vitro-Kultivierungssystems eine wichtige 
Rolle, da die Ergänzung eines essentiellen Nährstoffes in einem Wachstumsmedium zur 
Unterstützung des Wachstums, eine Schlüsselfunktion einnehmen kann. Neben den M. suis-
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Proteomdaten konnten im Untersuchungsmaterial auch erstmals Daten zu unterschiedlich 
exprimierten Sus scrofa Proteinen während einer M. suis Infektion quantitativ erfasst werden. 
Diese Informationen können in weiteren Studien dazu genutzt werden, infektions-relevante 
Prozesse im Wirt besser zu verstehen. 
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3 INTRODUCTION 
3.1 HEMOTROPHIC MYCOPLASMA  
3.1.1 HISTORY  
In 1928, the first anaplasma-like structures were detected by Schilling in blood smears 
collected from mice. The roundish particles on the surface of RBCs were named 
Eperythrozoon coccoides (Schilling 1928). Over the years Eperythrozoon-associated 
infections were described in different animals, e.g. sheep, goats and pigs (Moulder 1974; 
Zachary and Basgall 1985; Martin et al. 1988; Mason et al. 1989).  
 
The first Eperythrozoon infections in pigs were described in 1932 in the USA (Doyle 1932). 
As symptoms of this new infection thin blood, anemia and hemorrhages in different organs 
such as liver, spleen or heart were observed (Doyle 1932; Kinsley 1932). According to the 
appearance of the organism in blood smears the disease was firstly named as 
anaplasmosis-like disease (Doyle 1932; Kinsley and Rey 1934). Due to the similarities to 
Anaplasma-like particles in cattles (Eperythrozoon wenyonii) as well as in sheep and goats 
(Eperythrozoon ovis) the pig-specific pathogen was classified as Eperythrozoon suis (Splitter 
and Williamson 1950). In Germany the first E. suis infection of pigs was described in 1968 
during a suspicion of swine fever (Korn and Musgay 1968).  
 
3.1.2 TAXONOMY   
The taxonomic classification of HMs is still in progress. Based on 16S ribosomal ribonucleic 
acid (rRNA) gene sequence analysis and phenotypic characteristics, the genera 
Eperythrozoon and Haemobartonella out of the family Anaplasmataceae were transferred 
from the order Rickettsiales into the class Mollicutes, order Mycoplasmatales and family 
Mycoplasmataceae (Figure 1; Neimark et al. 2005). Since then, the organism 
Eperythrozoon suis is reclassified as Mycoplasma suis.  
 
To date, in Bergey's Manual of Systematic Bacteriology (2012) HMs are taxonomically 
classified within the order Mycoplasmatales, family Mycoplasmataceae in an uncertain 
taxonomic position (incertae sedis; Uilenberg et al. 2004; Hoelzle et al. 2014). 
INTRODUCTION      14 
 
 
Figure 1: Phylogenetic tree of HMs based on 16S rRNA gene sequences (Neimark et al. 2005). Mapped is the 
relationship between M. suis and other HMs. 
 
 
3.2 MYCOPLASMA SUIS  
3.2.1 MICROBIOLOGICAL PROPERTIES  
M. suis is a pleomorphic bacterium without a cell wall which is surrounded by a single 
membrane (Messick 2004). Electron microscopic analysis revealed that M. suis forms three 
different phenotypes, i.e. coccoid, discoid and ring structures (Zachary and Basgall 1985). 
M. suis is able to live freely in the blood plasma as well as attached individually or in chains 
to the surface of RBCs (Zachary and Basgall 1985). The bacteria are connected to the 
erythrocyte surface by fibrillary structures at a distance of approximately 30 nm (Zachary and 
Basgall 1985). This close contact between host cells and bacteria seems to be essential for 
the biology of M. suis. The unique parasitic lifestyle seems to be the main challenge for the 
establishment of a cultivation system for M. suis and other HMs. However, initial studies 
aiming on the cultivation of M. suis revealed culture persistence and nanotransformations 
(Schreiner et al. 2012a).  
 
Furthermore, it is known that M. suis is capable to invade into RBCs. Invasion and 
attachment lead to cell deformation and apoptosis (Hoelzle et al. 2003; Groebel et al. 2009; 
Felder et al. 2011). However, to date the mechanisms involved in adhesion, invasion and 
replication of M. suis are not unraveled in detail.  
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Whole genome sequencing of two different M. suis strains (M. suis Illinois, M. suis KI_3806) 
revealed deeper insights into the biology. Their circular, double-stranded genomes are 742  
kilo base pairs (kbp; M. suis Illinois) and 709 kbp (M. suis KI_3806) in size, corresponding 
genes encode 845 and 795 proteins, respectively (Messick et al. 2011; Oehlerking et al. 
2011). According to a significant genome reduction, other parasitic mycoplasmas with 
comparable genome sizes lack several metabolic pathways (Pollack et al. 1997; Moran 
2002). For M. suis these include genes for energy production by the pentose phosphate 
pathway as well as biosynthesis of amino acids i.e. the lack of the arginine biosynthesis 
pathway (Oehlerking et al. 2011; Felder et al. 2012). Nevertheless, M. suis and other 
mycoplasmas are self-replicating microorganisms (Messick et al. 2011; Barker et al. 2012). 
 
3.2.2 INFECTIOUS ANEMIA IN PIGS  
3.2.2.1   ETIOLOGY AND CLINICS  
Chronic and acute IAP is a multi-factorial disease caused by M. suis. Physiological stress, 
e.g. climatic factors such as high humidity and elevated temperatures as well as stress 
situations for example during birth or castration may induce outbreaks of IAP (Wu et al. 
2006). Infected animals suffer from acute life-threatening hemolytic anemia, mild hemolytic 
anemia or exhibit an asymptomatic infection depending on host susceptibility, pathogen 
virulence and infection dose (Heinritzi 1989; Guimaraes et al. 2011b). M. suis causes IAP in 
all age groups such as weaning piglets, pregnant sows and feeder pigs (Zachary and Basgall 
1985; Messick 2004). In a study investigating 1176 samples derived from German post-
weaning pigs representing approximately 196 pig fattening farms the prevalence of M. suis 
averaged 40,8% on pig farm level and 13.9% on single animal basis, respectively (Ritzmann 
et al. 2009). According to this finding, a similar study from Brazil indicated a M. suis 
prevalence of 18.2% based on single animals (Guimaraes et al. 2007). The high prevalence 
of M. suis infection in swine herds result in substantial economic losses to swine producers 
(Ritzmann et al. 2009). 
 
Clinical signs of acute anemia are associated with heavy M. suis bacteremia and include 
fever of up to 42°C, skin pallor, icterus, hypoglycemia and cyanosis at the ear tips (Zachary 
and Smith 1985; Heinritzi 1990; Messick 2004). The decline of blood glucose occurs very 
quickly (Heinritzi 1990). During hypoglycemia animals suffer from muscular cramps and 
comatose conditions until they die (Heinritzi 1990).  
The chronic course of IAP is signed by mild anemia, mild icterus, reduced reproduction rates 
and poor growth rates (Henry 1979; Gresham et al. 1994). Furthermore, allergic skin 
reactions, circular disorder and hemorrhage can be observed in M. suis chronic infected pigs 
(Henry 1979; Gresham et al. 1994). Pigs chronically infected with M. suis are predisposed to 
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secondary infections of the respiratory and intestinal tract (Henry 1979). These include 
porcine influenza, enzootic pneumonia in pigs, pasteurellosis, toxoplasmosis or porcine 
reproductive and respiratory syndrome (Wu et al. 2006).  
 
3.2.2.2   EPIDEMIOLOGY AND PATHOGENESIS  
M. suis is especially transmitted between pigs via blood-associated routes. In this connection 
the iatrogenic way seems to predominate. Especially contaminated surgical instruments (e.g. 
needles, scalpels) act as M. suis transmission pathways between pigs during vaccination or 
castration (Heinritzi 1990). Through bloody hierarchic encounters M. suis can be transferred 
among boars (Hoelzle et al. 2010). Furthermore, arthropods such as Haematopinus suis, 
Stomoxys calcitrans and Aedes aegypti are discussed in the agent transmission (Prullage et 
al. 1993; Messick 2004). Moreover, piglets can also be infected by the dam in utero or during 
birth (Henderson et al. 1997). The main challenge in epidemiology is associated with 
asymptomatically infected pigs. These animals remain unrecognized and act as carrier and 
transmitters within and between swine herds (Hoelzle et al. 2009).  
 
Further information on M. suis pathogenesis are still required. Two main disease complexes 
are identified, i.e. anemia and hemorrhages. 
In anemia, destruction of RBCs is caused by the close contact of M. suis to the surface of 
RBCs, invasion into the RBCs, eryptosis and the induction of autoreactive antibodies 
directed against RBC components, respectively (Zachary and Basgall 1985; Felder et al. 
2010; Hoelzle et al. 2014). 
The close parasitic contact from M. suis to the surface of RBC is possible by the expression 
of surface-localized membrane proteins. These proteins act as an essential juncture between 
the bacteria and the host. Only three M. suis surface proteins (heat shock protein A1 
(HspA1), GAPDH-like protein 1 (MSG1), and α-enolase have been investigated in detail so 
far (Hoelzle et al. 2007b; Hoelzle et al. 2007c; Schreiner et al. 2012b). MSG1 and α-enolase 
are so-called “moonlight proteins” since they can perform two different functions in two 
different subcellular locations. Their main function is energy production by glycolysis (Hoelzle 
et al. 2007c; Schreiner et al. 2012b). Furthermore, α-enolase as well as MSG1 can be 
localized to the exterior of the cytoplasmic membrane and seem to be essential during the 
adhesion process (Hoelzle et al. 2007c; Schreiner et al. 2012b). Moonlight proteins could 
save significant amounts of energy in reproduction and growth, because the organism 
exhibits fewer proteins and consequently has fewer DNA which need to be replicated (Jeffery 
1999).  
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Nevertheless, the close host-pathogen contact leads to RBC damage as well as lysis and 
eryptosis, respectively (Hoelzle et al. 2007c; Felder et al. 2011). Typical characteristics of 
eryptosis are membrane blebbing, activation of proteases and cell contractions (Felder et al. 
2011). Until now, it has not been clarified by which mechanisms eryptosis is triggered during 
M. suis infection.  
Interestingly, M. suis is capable of actively invading RBCs. This property seems to be 
important for the metabolic activity of these bacteria but nevertheless, lead also to RBC 
destruction (Groebel et al. 2009). 
Autoreactive antibodies induced in M. suis infected pigs is a long known phenomenon in IAP 
(Zachary and Smith 1985; Hoelzle 2008) leading to autoimmune hemolytic anemia (AIHA; 
Felder et al. 2011). In IAP two different forms of AIHA are observed, i.e. cold and warm 
AIHA. 
In the cold AIHA autoreactive antibodies bind to their target antigen at low temperatures 
(4°C) and in warm AIHA the target epitope is bound by the immune globulin (Ig) at body 
temperature (Felder et al. 2010). During both AIHAs the up-regulated autoreactive antibodies 
are directed against RBC components leading to erythrocyte death (Felder et al. 2010).  
In detail, the RBCs undergo changes when M. suis attaches to their surface, which in turn 
induces IgM cold agglutinins during IAP (Zachary and Smith 1985; Hoelzle 2008). Cold 
agglutinins belong to the IgM isotope and are directed against carbohydrate antigens 
expressed on the erythrocyte surface (Zachary and Smith 1985). IgM autoantibodies exhibit 
maximal reactivity at 4°C. Therefore, certain body parts in which the body temperature is 
rather low, e.g. ears and tails are affected by blood agglutinations (Zachary and Smith 1985). 
Moreover, M. suis infection induce a misdirected immunoregulation and suppresses the T-
lymphocyte blastogenic response (Zachary and Smith 1985). At the same time, the 
polyclonal B-lymphocyte activation and the production of autoreactive IgM (cold agglutinins) 
increase (Zachary and Smith 1985).  
Warm autoreactive IgG antibodies are also formed during M. suis infections. Interestingly, 
these autoreactive antibodies bind to the actin of RBCs which leads to erythrocyte damage 
(Felder et al. 2011). Additional investigations proved that these autoreactive antibodies are 
species-specific and are induced by a process that is known as molecular mimicry (Felder et 
al. 2011). So, the formation of these antibodies is induced by an epitope on the MSG1 
protein on the surface of M. suis (Felder et al. 2011). 
 
Moreover, IAP is associated with coagulation dysfunction as well as hemorrhagic diathesis 
(Sokoli et al. 2013).  
M. suis triggers intravasal coagulation followed by consumption coagulopathy in its host. 
Sokoli and co-workers proved also the affection of endothelial cells (ECs) during M. suis 
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infection as a possible cause of hemorrhages (Sokoli et al. 2013). The results of the study 
showed that the endothelial cells of the abdominal aorta are infected and destroyed during 
M. suis infection leading to cellular gaps within the endothelium (Sokoli et al. 2013). At these 
sites aggregated blood cells infected by M. suis were identified as red dots, respectively as 
arterial thrombi (Sokoli et al. 2013). Additionally, it was possible to visualize a network of 
fibrin fibers in which RBCs and leukocytes are embedded (Sokoli et al. 2013).  
 
3.2.2.3   DIAGNOSIS AND THERAPY  
Beyond the detection of acute clinical apparent infections the main challenge is the 
identification of asymptomatically persistent infected pigs which can act as carriers and 
transmitters (Hoelzle et al. 2009). Therefore, direct and indirect diagnostic methods were 
established to diagnose M. suis infections in pigs. 
A classical direct diagnostic method is the microscopic detection of M. suis in blood smears. 
For this, blood slides are heated up to 37°C to avoid agglutination and stained with acridine 
orange (Figure 2). However, detection is only possible during maximum bacteremia when 
more than 80% of the RBCs contain M. suis. Comparative M. suis prevalence studies 
showed that only 35 samples out of the 164 M. suis-PCR positive samples were also positive 
by microscopy (Ritzmann et al. 2009). Therefore, microscopy is limited by its low sensitivity 
and specificity (Hölzle et al. 2007a).  
 
 
Figure 2: Microscopic picture of single M. suis cells and attached to RBCs during acute IAP in blood smears; 
1000× magnification. 
Today, PCR-based methods are the first choice in M. suis diagnosis since these approaches 
enable the detection of acute as well as of chronic infected pigs. The Light Cycler Rt-PCR 
represents a quantitative detection method (Hoelzle et al. 2007a). Due to its high degree of 
standardization and reproducibility as well as the low risk of contamination it is used in 
routine laboratory diagnostics. To achieve high sensitivity and specificity the gene sequence 
of the immunodominant MSG1 protein was used to generate specific primer and probes. The 
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test sensitivity amounts to 100% with a specificity of 97.6%. This approach is a powerful tool 
for studies examining the prevalence and pathogenesis of chronic and acute anemia 
infections in pigs (Hoelzle et al. 2007a). 
Additionally, a Rt-PCR assay based on a TaqMan probe has been established (Guimaraes et 
al. 2011a). To obtain a highly sensitive and specific detection of M. suis the assay is based 
on the 16S rRNA gene encoded by M. suis strain Illinois (Guimaraes et al. 2011a). 
 
Three different serological detection methods have been described: i) complement fixation 
test (Splitter 1958; Schuller et al. 1990) ii) indirect hemagglutination test (Baljer et al. 1989) 
iii) enzyme-linked immunosorbent-test (ELISA; Hsu et al. 1992; Hoelzle et al. 2006; Hoelzle 
et al. 2007d; Zhang et al. 2008).  
ELISA was used for the detection of M. suis-specific serum antibodies. However, the major 
drawbacks of M. suis serology is the fact that during the clinically acute phase of the M. suis 
infection autoreactive antibodies and M. suis-specific serum antibodies appears 
simultaneously leading to a masking during the detection of M. suis-specific antibodies 
(Hoelzle et al. 2006). In addition, especially the cold agglutinins are constitutive parts in the 
M. suis test antigen preparations derived from infected and diseased pigs (Hoelzle et al. 
2006). Therefore, the sensitivity and the specificity is limited in ELISAs using whole cell 
antigens from the blood of infected animals (Hoelzle et al. 2006). The depletion of 
immunoglobulins from the test antigen could improve the serodiagnosis by indirect ELISA 
(Hoelzle et al. 2006). However, further Western Blotting studies indicated that the 
immunodominant proteins p40, p45 and p70 can act as serological markers proving a M. suis 
infection (Hoelzle et al. 2006).  
Therefore, two (p40, p70) out of the indicated three antigens were recombinantly expressed 
in Escherichia coli (Hoelzle et al. 2007d). Based on these diagnostic antigens it was possible 
to establish a highly sensitive and specific ELISA which is independent from animal 
experiments (Hoelzle et al. 2007d). Recombinant ELISA is a serological test which can be 
used in routine diagnostics in standard laboratories for pathogenesis studies and 
epidemiological researches (Hoelzle et al. 2007d). 
In 2012 a novel, specific and sensitive blocking ELISA based on horseradish peroxidase 
(HRP)-labeled monoclonal antibodies (1A7) was established (Zhang et al. 2012). 
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3.2.2.4   INFECTION MODEL 
Little is known about the pathophysiology of M. suis, due to the fact that an in vitro cultivation 
system is still missing. For the investigation of M. suis infections an in vivo model, the 
splenectomized M. suis pig model, is used. This infection model enables the experimental 
investigation of the acute M. suis infection. For this, five-week old piglets are splenectomized 
according to the method of Heinritzi (Heinritzi 1984a; Heinritzi 1992). The piglets are infected 
intramuscularly with M. suis-positive blood one week after splenectomy. The course of the 
disease and the clinical signs are comparable to natural infected animals suffering from 
acute anemia. 
Many milestones of M. suis research are based on the well-established pig infection model 
which is used since more than 30 years. For example, the infection model was applied in 
several studies dealing with diverse aspects of M. suis infections, such as intra-uterine 
infections (Heinritzi 1992), the transmission by arthropods (Prullage et al. 1993), the 
attachment to RBCs and replication (Zachary and Basgasll 1985) and the identification of a 
misdirected immune response (Zachary and Smith 1985). Moreover, cold agglutinins in 
M. suis-infected pigs could be isolated (Schmidt et al. 1992) and the verification of antibodies 
during different time points of infection with the indirect hemagglutination test were carried 
out (Baljer et al. 1989). Furthermore, molecular biological studies on surface-proteins with 
adhesion properties could be performed without a cultivation system (Hoelzle et al. 2007b; 
Hoelzle et al. 2007c; Schreiner et al. 2011). Hoelzle and co-workers succeeded in the 
identification of anti-MSG1 and anti-HspA1 antibodies in pigs (Hoelzle et al. 2007d) and 
Groebel and co-workers detected the invasive behavior in RBCs (Groebel et al. 2009). 
Additionally, the establishment of an in vitro cultivating system was supported by results 
gained from the infection model (Schreiner et al. 2012a).  
 
Nevertheless, at the moment there is no established pig infection model available which can 
be used to investigate chronic anemia in pigs. The establishment of a chronic M. suis-pig 
infection model would have some substantial benefits. Firstly, we could use the natural host 
resembling the natural infection. Secondly, we would have access to blood samples 
containing high numbers of in vivo grown M. suis at the time of bacteremia. In combination, 
both established infection models (acute, chronic) could allow us to investigate the 
pathogenesis, immunology, and clinics of acute as well as chronic IAP under standardized 
conditions in future. Therefore, the establishment of a second infection model is necessary.  
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3.3 OMICS  
Omics technologies target the holistic analysis of a defined biological system at a given point 
of time based on the analysis of all detectable molecules of DNA, RNA, proteins or 
metabolites, namely genomics, transcriptomics, proteomics and metabolomics (Figure 3). 
Genomics deals with the complete DNA sequence of an organism and serves as the 
blueprint of life (Lee et al. 2005). Transcriptome analysis only deals with expressed genes 
based on RNA detection (Lee et al. 2005). Protein profiles (proteomics) of organisms are 
analyzed by gel electrophoresis coupled with liquid chromatography and tandem mass 
spectrometry (LC-MS/MS; Lee et al. 2005). Metabolomic analysis is based on whole sets of 
metabolites at a certain time point. They are usually measured by gas chromatography 
coupled to tandem MS (GC-MS/MS) or nuclear magnetic resonance (NMR; Lee et al. 2005). 
 
Figure 3: The field of omics-methods. Genomes are sequenced by DNA sequencer. Microarrays read mRNA-
profiles to detect the transcriptome, whereby proteome reflect all expressed proteins measured combined by gel 
electrophoresis and LC-MS/MS analysis. In metabolome profiling GC-MS, LC-MS and NMR technologies are 
used. 
 
3.3.1 PROTEOME ANALYSIS  
Proteome analysis is used to gain insights into the biological mechanisms at the molecular 
level (Roe and Griffin 2006). They are especially performed to identify single proteins, but it 
is also possible to obtain information on protein modification, localization, protein-protein 
interactions and their functional roles (Fields 2001). The proteome is a dynamic collectivity 
interlocked by expressed proteins at a precise point in time in an organism, cell or tissue 
(Lee et al. 2005).  
In proteome analysis, “gel-free” 1-dimensional electrophoresis (DE) or gel-based 2-DE can 
be used to separate proteins according to their biochemical properties. A lot of proteome 
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studies applied 2-DE for the fractionation of complex samples, but for insoluble proteins this 
method is of limited value (Old et al. 2005). Separated proteins from 1-DE are isolated and 
digested by trypsin. Subsequently, the specific spectra of peptides are measured by LC-
MS/MS (Lee et al. 2005). 
For the MS-based proteome analysis of complex samples, MS has progressively become the 
method of choice, distinguished by a Nobel Prize in chemistry in 2002 (Aebersold and Mann 
2003). MS measurements scale the mass-to-charge ratio (m/z) of the ionized analyte and a 
detector registers the number of ions at each m/z value (Aebersold and Mann 2003). The 
standard types of mass analyzers are: time-of-flight (TOF), ion trap, Fourier transform ion 
cyclotron and quadrupole which are routinely used (Aebersold and Mann 2003). 
To get more insights into M. suis pathogenesis, proteome analysis were performed. The first 
M. suis proteome report was published in 2009. In this study, 191 out of 794 (24.1%) 
encoded proteins could be detected by cross-species-identification missing a fitting protein 
database (Yuan et al. 2009).  
The first proteome study based on specific HM genome sequences provided basic 
knowledge about the M. suis gene expression profile during an acute HM infection. In this 
study, 179 out of 794 encoded M. suis proteins (22.5%) were found to be expressed (Felder 
et al. 2012). The identified proteins mainly include well-defined proteins of the energy, 
carbohydrate and nucleotide metabolism, translation, transcription, DNA repair and some 
putative virulence factors (Felder et al. 2012). Only a few of the many encoded hypothetical 
and surface M. suis proteins were found to be expressed during infection by this approach 
(Felder et al. 2012). 
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4 OBJECTIVES 
M. suis is found worldwide in the pig industry as an important cause of IAP in different age 
classes. An efficient diagnostic method for M. suis is the quantitative Rt-PCR. The 
quantitative M. suis diagnostic tool works with high sensitivity and specificity. Therefore, it 
can be applied during acute IAP (up to 106 - 109 M. suis cells/ml blood) as well as during 
chronical infections (up to 103 – 105 M. suis cells/ml blood). Chronically M. suis infected pigs 
cause significant economic losses in swine production due to growth retardation rates, 
reduced reproduction efficiency of sows and an increased susceptibility to secondary 
infections (viral, bacterial). 
 
To get further information on the pathogenesis of the chronic persistent M. suis infection the 
corresponding pig infection model has to be established.  
 
In addition, using experimental infection pig models (acute, chronic) investigations on 
possible transmission pathways of M. suis can be performed. Until now, only blood- 
associated transmission pathways have been detected for M. suis. However, further 
shedding patterns are probable. 
 
Furthermore, bacterial preparation from the M. suis-pig infection model contains large 
numbers of M. suis bacteria as well as several amounts of porcine components. Based on 
the genome sequencing it is possible to gain insights into the gene expression profile of 
M. suis and S. scrofa, respectively. Proteomic studies help to understand the mechanism 
M. suis uses to cause disease and to establish persistence in the host. The expressed 
membrane-associated proteins of M. suis are important key players in the uptake of nutrients 
(transporters) from the RBCs and the interaction between the pathogen and the host. This 
knowledge could be helpful to establish a cultivating system for M. suis, and to get new 
available therapies as well as prophylaxis methods. 
 
The aim of this work was to establish a chronic-infection pig model, to identify further 
transmission pathways of M. suis and to update the single existing proteome profile to gain 
more knowledge about the pathophysiology of M. suis.  
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The objectives are listed in detail as follows: 
 
4.1 Establishment of a chronic IAP simulated under experimental conditions 
- The characterization of the course of experimental M. suis infection in splenectomized 
and non-splenectomized pigs using the highly virulent and RBC-invasive strain 
KI_3806. 
- Determine whether both, chronic and acute forms of IAP, can be simulated under 
experimental conditions. 
 
 
Major conclusions:  
- Experimental infection with the highly virulent and invasive M. suis strain KI_3806 in 
non-splenectomized pigs lead to chronic IAP. 
- Well-established infection models are important for further pathogenesis studies in 
M. suis. 
- Clinical and hematological parameters allow insights into the host immune response 
during acute and chronic IAP. 
 
 
These topics are addressed by the following article: 
Stadler J, Jannasch C, Mack SL, Dietz S, Zöls S, Ritzmann M, Hoelzle K, Hoelzle LE. 
Clinical and haematological characterisation of Mycoplasma suis infections in 
splenectomised and non-splenectomised pigs. Vet Microbiol. 2014 Aug 6;172(1-2):294-300. 
doi: 10.1016/j.vetmic.2014.05.012. Epub 2014 May 13. 
Link: http://www.sciencedirect.com/science/article/pii/S037811351400248X 
Copyright ELSEVIER B.V., reproduced with permission. 
License number: 3815990504308  
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4.2 Investigation of potential transmission routes of M. suis 
- Characterization of M. suis shedding during experimental infection in order to get 
insights into potential transmission pathways. 
 
 
Major conclusions:  
- M. suis shedding is found in urine, as well as salivary, nasal and vaginal secretion but 
not in feces. 
- Blood-independent direct transmission and indirect transmission via environmental 
contamination may play a role in the epidemiology of M. suis infections 
 
 
These topics are addressed by the following article:  
Dietz S, Mack SL, Hoelzle K, Becker K, Jannasch C, Stadler J, Ritzmann M, Hoelzle LE. 
Quantitative PCR analysis of Mycoplasma suis shedding patterns during experimental 
infection. Vet Microbiol. 2014 Aug 27;172(3-4):581-5. doi: 10.1016/j.vetmic.2014.06.019. 
Epub 2014 Jul 2. 
Link: http://www.sciencedirect.com/science/article/pii/S0378113514003113 
Copyright ELSEVIER B.V., reproduced with permission. 
License number: 3815990083172 
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4.3    Mechanisms used by M. suis to cause disease and to establish persistence in the 
host 
 
- Comprehensive proteome analysis of M. suis-infected porcine blood from samples 
containing low and high bacterial loads. 
- Establishment of an improved protocol for proteome analysis of M. suis derived from 
EDTA-blood samples.  
- Identification of expressed M. suis transporter system during acute IAP. 
 
 
Major conclusions:  
- The improved protocol led to the identification of 404 M. suis proteins in samples 
containing high bacterial loads. 
- Surface-localized proteins which act as connecter between host and pathogen could 
be predicted by software tools and identified by proteome analysis. 
- Identification of membrane proteins indicate that several nutrients are taken up by 
M. suis during IAP. 
 
 
These topics are addressed by the following article:  
Dietz S, Lassek C, Mack SL, Ritzmann M, Stadler J, Becher D, Hoelzle K, Riedel K, Hoelzle 
LE. Updating the proteome of the uncultivable hemotrophic Mycoplasma suis in 
experimentally infected pigs. Proteomics. 2016 Feb;16(4):609-13. doi: 
10.1002/pmic.201500238. 
Link: http://onlinelibrary.wiley.com/doi/10.1002/pmic.201500238/abstract 
Copyright Wiley-VCH Verlag GmbH & Co. KGaA, reproduced with permission. 
License number: 3816011028815 
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5 PUBLICATIONS 
The scientific work especially in the leader author publications were realized by S. Dietz and 
supervised by L. E. Hoelzle. Conception as well as preparation of all three manuscripts was 
done in team work with the mentioned authors. 
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5.1 Clinical and haematological characterisation of 
Mycoplasma suis infections in splenectomised 
and non-splenectomised pigs  
 
Veterinary Microbiology 172 (2014) 294–300 
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Abstract 
The hemotrophic bacterium Mycoplasma suis provokes infectious anemia in pigs (IAP). IAP 
is clinically described by chronic mild or acute life-threatening hemolytic anemia. The inability 
to culture M. suis necessitate the experimental infection of splenectomized pigs for detailed 
pathogenesis studies. Aim of the present study was to establish a pig infection model 
remodeling the chronic course of infection. For this, the experimental course of the disease in 
splenectomized and non-splenectomized pigs was compared to clarify the interdependency 
between clinical and hematological parameters and the M. suis blood loads. Therefore, we 
infected two groups of pigs using the highly virulent and red blood cell invasive M. suis strain 
KI_3806. On day 2 post infection (p. i.), all 7 pigs of group 1 (splenectomized) were proved 
as PCR-positive. The maximum mean bacterial loads were reached on day 8 p. i. with 
concentrations of 1.6 x 1010 M. suis/mL. Clinical symptoms such as severe anemia as well as 
massive hypoglycemia could be observed, hence the pigs were euthanized. All pigs of group 
2 (non- splenectomized) were PCR-positive at least on day 23 p. infection. Maximum mean 
bacterial loads of 1.64 x 105 M. suis/mL were found on day 8 p. infection. Until day 35 p. i. all 
animals exhibited typically clinical symptoms, i.e. mild anemia, massive skin alterations with 
petechiae, hemorrhagic diathesis. Furthermore, seroconversion could be detected in blood 
samples.  
These results demonstrate a mild form of IAP in non-splenectomized pigs infected with the 
highly virulent strain KI_3806 that is similar to the clinical situation found during natural 
infections. On contrary, infection of splenectomized pigs with KI_3806 leads to severe and 
life-threatening IAP. In summary, both infection models evaluated in this study can be used 
for further pathogenesis research of chronic and acute IAP. 
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5.2 Quantitative PCR analysis of Mycoplasma suis 
shedding patterns during experimental 
infection 
 
Veterinary Microbiology 172 (2014) 581–585 
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Abstract  
Mycoplasma suis belongs to the uncultivable hemotrophic mycoplasmas and induces 
infectious anemia in pigs. Transmission pathways as well as transmission mechanism 
between pigs are mostly unknown. To get deeper insights into transmission pathways of 
M. suis, we analyzed environmental samples, urine, feces as well as nasal, vaginal and 
saliva secretions for M. suis DNA by quantitative LightCycler msg1 PCR. For this, non-
splenectomized pigs were experimentally infected with the highly virulent M. suis strain 
KI_3806. On day 6 post infection, M. suis DNA was detected in saliva, nasal and vaginal 
secretions, with a quantity of 3.4 x 102 to 2.7 x 105 M. suis/swab. Shedding was found in all 
urine samples (100%) from day 6 p. i., with a quantity of 4.7 x 102 to 6.3 x 105 M. suis/mL. 
Moreover, M. suis DNA could be detected on day 2 and 6 p. i. in dust and water samples of 
the pig drinking troughs. However, in all feces and air-samples M. suis DNA could not be 
detected at all. These results indicate that blood independent transmission pathways (indirect 
and direct) could play an important role in the epidemiology of M. suis infections in pig farms. 
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5.3 Updating the proteome of the uncultivable 
hemotrophic Mycoplasma suis in 
experimentally infected pigs 
 
Proteomics 16 (2016) 609–613 
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Abstract 
The uncultivable bacterium Mycoplasma suis is one member of the hemotrophic 
mycoplasmas which are associated with chronic and acute anemia in livestocks worldwide. 
Up to now, it is not possible to culture M. suis in vitro complicating the characterization of 
M. suis on the molecular level. Only one proteome study based on the M. suis KI_3806 
genome has been published so far. In the present comprehensive proteome study we used 
three different M. suis protein extraction methods followed by 1D SDS-PAGE and LC-
MS/MS. In total, 50.8% of the predicted M. suis proteins (404 out of 795) were identified. 
Moreover, 83.7% of the detected M. suis proteins could be assigned to functions. 
Interestingly 34.2% of the encoded M. suis hypothetical proteins could also be proved as 
expressed during acute infection. Further detailed computational analyses revealed 
information that some of these expressed hypothetical proteins are membrane-associated 
which could be involved in host-pathogen interaction or adhesion process. In addition, 
analyses of the expressed proteins indicate the presence of one ECF-transporter as well as 
a hexose-6-phosphat-transporter. Taken together, these proteome results are important 
steps to unravel the specific and unique life style of M. suis and help to establish an in vitro 
culture system in future.   
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6 SUMMARISING DISCUSSION  
The lack of an in vitro cultivation system for HMs is one of the main challenges to obtain 
insights into their pathobiology.  
Until now the establishment of an in vitro cultivation system for M. suis was not successful 
(Hoelzle 2008). Only one study succeeded to maintain M. suis in a cell-free medium 
(Schreiner et al. 2012a). This medium contained iron-supplements (porcine hemin, 
hemoglobin) since in many cases iron is the limiting factor for bacterial growth (Schreiner et 
al. 2012a). M. suis metabolism is apparently glucose-dependent, based on the fact that life-
threatening hypoglycemia is one general clinical sign of IAP (Heinritzi 1990). Therefore, 
glucose-supplemented media were tested for growth of M. suis (Schreiner et al. 2012a). 
Nevertheless, the growth conditions seem to be suboptimal since the M. suis cells underwent 
transformation processes leading to so-called nanoforms (Schreiner et al. 2012a).  
Due to this fact HM research is crucially based on the usage of experimentally infected 
animals for the propagation of these specialized bacteria. However, most HMs exhibit strict 
host specificity which means that we have to use homologous animal models.  
 
Experimental chronic pig model 
Typically, experimental M. suis infections are performed with six-week old M. suis-free 
piglets. One week after splenectomy (Heinritzi 1984a) piglets are intramuscularly infected 
using M. suis-positive blood. This model based on splenectomized piglets is very useful to 
induce the acute course of IAP (Hoelzle et al. 2006). In addition, animals produce high 
bacterial loads rising up to 1010 bacteria per ml blood on day 8 or 10 post infection (p. i.; 
Figure 4A).  
 
 
Figure 4: Bacterial loads in porcine blood samples during experimental infection with M. suis strain KI_3806 
measured by Rt-PCR. A) Acute experimental infection model (n=7), B) chronic experimental infection model 
(n=7). 
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With regard to animal welfare, pig scoring systems are used to evaluate the clinical 
conditions after experimental M. suis infection and to define interruption criteria for the 
experiments (Stadler et al. 2014). Based on these scores, animals exceeding three scoring 
points per day are treated with glucose and tetracycline; a scoring higher than 5 leads to the 
euthanasia of the affected piglets. 
 
As aforementioned, chronic M. suis infections in pigs are very important with the regard of 
epidemiology and economic losses. Therefore, the aim of this work was to establish a pig 
infection model which is suitable to simulate and investigate the chronic course of infection.  
For this a novel model based on non-splenectomized pigs was established. Six-week old 
piglets were infected intramuscularly with a highly virulent and invasive M. suis strain 
(KI_3806). By doing this, the experimentally infected animals exhibited clinical symptoms 
typical for the chronic course of the M. suis infection, i.e. mild anemia and Morbus maculosus 
(Figure 5A, B, C). 
 
 
Figure 5: Clinical symptoms (Morbus maculosus) A) at the ears, B) the flanks and C) the belly of M. suis infected 
pigs 
 
Natural chronic IAP is characterized by cyclic variations of bacterial loads, i.e. anemia 
attacks with high bacterial numbers in the blood are followed by low bacteremia phases 
(Zachary and Smith et al. 1985, Heinritzi et al. 1990a; Heinritzi et al. 1990b). Interestingly, 
these cyclic variations of bacterial loads in blood samples could also be observed in our 
chronic infection model (Figure 4B).  
We found experimentally infected animals even with phases in which M. suis could not be 
detected in the blood stream (Figure 6A, B). Nevertheless, in these periodically M. suis blood 
negative animals bacterial levels increased after a few days leading even to anemia attacks. 
This periodically course of the bacterial blood level is a typical observation of chronic IAP and 
could be demonstrated also in our study (Zachary and Smith et al. 1985, Heinritzi et al. 
1990a; Heinritzi et al. 1990b). 
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Figure 6: Bacterial loads in blood samples from two experimentally infected pigs (A, B) during the chronic course 
of IAP. The animals were infected by M. suis strain KI_3806 and bacterial loads were measured by Rt-PCR. 
 
 
The localization of M. suis during these blood PCR-negative time points has not been 
clarified yet. However, we suggest some similarities to the lifestyle of 
Plasmodium falciparum. This organism also parasites the RBCs of his host, uses the 
bloodstream to spread throughout the host and settles in tissues (Prudêncio et al. 2006). 
P. falciparum migrates to the liver, where it can infect the hepatocytes (Prudêncio et al. 
2006). For M. suis, the invasion into erythrocytes is already verified and the bacterial load 
can be measured in blood samples. Based on the periodically observed negative results for 
M. suis in blood during experimental infection, it can also be speculated that M. suis may be 
hidden in cells of the viscera during the blood negative periods. This hypothesis is supported 
by the fact that in immunohistochemical investigations M. suis could be detected in liver, 
mesenteric lymph nodes, heart and lungs associated with massive alterations in the tissue 
structure (Sokoli et al. 2013). In addition, macroscopic organ changes such as brightened or 
blemish livers, hyperemia, as well as single randomized beige foci up to 5 mm in diameter or 
single white foci could be observed in experimentally M. suis infected pigs (unpublished 
data).  
The major energy source of M. suis seems to be glucose which is synthesized in the liver by 
gluconeogenesis. Additional nutrients such as iron, amino acids, sodium, calcium, 
magnesium and potassium are also available in the liver environment. It is possible that the 
invasion in liver cells represents a silent stage of infection.  
In summary, the established novel chronic infection model provides some substantial 
benefits; first it enables the investigation of chronic infection during natural conditions (natural 
host) over a long period of time. Secondly, the mechanisms leading to the economically 
important persistent M. suis infections can be monitored. In combination with the acute 
infection model (experimental infection after splenectomy) the novel model simulating the 
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chronic course of infection is very worthwhile for the clarification of the M. suis pathobiology 
in future. 
 
Transmission 
One essential prerequisite in fighting against transmissible pathogens is to know all the 
possible epidemiological pathways that can be used by this infectious agent. 
It is well known that during M. suis infections blood-associated pathways are of central 
importance. As vehicles act contaminated needles and scalpels, but also arthropods are 
discussed (Heinritzi 1990; Prullage et al. 1993; Messick 2004). Moreover, animals can be 
infected by direct blood transfer during bloody rank fights (Henderson et al. 1997; Hoelzle et 
al. 2010). These transmission pathways, especially the iatrogenic as well as vector based 
transmission pathways are efficiently reduced within the modern pig husbandries. 
Nevertheless, M. suis infections are an emerging problem in pig production. Therefore, we 
suggest that other pathways have to be of epidemiological significance. 
In order to clarify this, the second aim of the study was to identify potential blood-
independent transmission pathways also in acute and chronic M. suis infections. This was 
enabled by the availability of both described infection models (Heinritzi 1984b; Hoelzle et al. 
2003; Stadler et al. 2014). 
In samples gained from acute infected pigs, we identified and quantified M. suis DNA in 
nasal, vaginal and saliva swabs as well as in urine samples from day 6 p. infection. We 
observed that M. suis detection in secretions and urine correlated with the bacterial load in 
blood samples. Therefore, we suggest that blood-independent shedding of bacteria is 
obviously nonetheless coupled with high bacterial blood loads.  
The course of chronic infection is more common in naturally infected pigs and is 
characterized by low bacteremia. However, employing the chronic model enabled the 
chronological sampling and analysis of nasal, vaginal and saliva swabs as well as urine 
samples for 84 days p. infection. We identified that an excretion via these secretions is 
isolated and rarely possible during chronic IAP in single pigs on days 6, 21, 28 and 42 p. i. 
(unpublished data). 
For the first time our results indicate the excretion of M. suis via blood-independent 
transmission pathways including different secretions (nasal, vaginal and saliva) as well as 
urine during chronic IAP.  
The excretion via vaginal secretions could also be responsible for M. suis transmission. A 
transmission via vaginal secretions could already be observed for Streptococcus suis during 
parturition (Robertson et al. 1991). Interestingly, it was shown that M. suis transmission from 
dam to unborn piglets in utero was first described a few years ago (Henderson et al. 1997). 
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Nevertheless, it should be clarified whether the transmission occurs via blood or by oral 
ingestion of vaginal secretions during parturition.  
Excretion via saliva could represent an important transmission pathway of M. suis, especially 
in boars. Boar fattening is associated with hierarchic encounters and aggressive behavior 
including biting and pressing against the cages (Cronin et al. 2003). Furthermore, tail biting 
and ear biting constitute abnormal social behavior in pigs and could also be responsible for 
transmissions of M. suis through infected saliva (Brunberg et al. 2011). Moreover, we 
observed that after M. suis infection water samples from pig drinking thoughts were tested 
positive (Dietz et al. 2014). We hypothesize that contamination of pig drinking thoughts by 
M. suis excretions via saliva, could represent a potential transmission pathway especially in 
the group housing of pig farming.  
Saliva is also used for diagnostic purposes due to its ready accessibility and ease of 
collection (Aps and Martens 2005). Consequently, saliva plays an important role in 
transmission for other pathogens. Nevertheless, our study indicates that the excretion during 
high bacterial loads seems to be coupled to the shedding of M. suis via secretions. This 
underpins the hypothesis that a bacterial load of 107 M. suis cells/ml blood constitutes the 
threshold value for excretion. Consequently, the detection of M. suis DNA in saliva and nasal 
secretion samples for diagnostic purposes are insufficient at this stage of infection. 
Therefore, blood sampling is still necessary to safely diagnose M. suis infections in pigs. 
Interestingly, against former research studies (Heinritzi 1992), we could also detect M. suis in 
RBC-free urine from acute and chronically infected pigs. Therefore, RBCs-free urine can also 
be considered as a potential transmission pathway since pigs drink each other’s urine.  
Our results underpin the hypotheses that M. suis transmission during acute and chronic IAP 
can also occur blood-independent. These blood-independent transmission pathways via 
saliva, vaginal secretions and urine may take place during standard pig farming, i.e. 
parturition or feeding. Based on our assumptions we suggest that the epidemiological 
variations of M. suis was underestimated during the last decades. These results represent a 
milestone in the investigation of the M. suis epidemiology and shed light on further M. suis 
transmission pathways besides blood and arthropods. 
 
Proteome analysis  
The sequencing of genomes from pathogens has opened the doors for proteome analysis 
(Hanash 2003). The comparative investigation of the proteome of a pathogen under specified 
conditions (environment, course of infection etc.) can help to acquire knowledge about the 
differential expression of the genes within these certain situations. Therefore, proteomic 
analysis can be used to identify new biomarkers, and for a better understanding of the 
pathobiology as well as to support drug evolution (Hanash 2003). Only a few proteome 
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studies on cultivated mycoplasmas are published until today. These include M. genitalium 
strain G37, M. hyopneumoniae strain 232 and M. mobile strain 163K (Wasinger et al. 2000; 
Jaffe et al. 2004; Pendarvis et al. 2014). For these strains 33%, 70% and 80% of the 
predicted proteins could be detected, respectively (Wasinger et al. 2000; Jaffe et al. 2004; 
Pendarvis et al. 2014). 
To deepen our knowledge about the gene expression of M. suis during acute infection the 
third goal of this work were proteomics-based investigations of M. suis. To this end, we 
performed proteome analysis of the M. suis strain KI_3806 on day 4 and day 8 p. i. 
(Figure 7).  
A previous proteome study of M. suis from Felder and co-workers (2012) applied a M. suis 
enrichment prior to protein analysis. Based on this work we improved the M. suis enrichment 
protocol and complemented proteome analysis by two additional protein fractions to achieve 
higher number of protein identifications during the different phases of infection.  
 
Figure 7: The diagram represents the bacterial load of porcine EDTA-blood samples on day 4 and 8 p. i. from 
three biological replicates measured by Rt-PCR (left x-axis). Furthermore, it depicts assigned spectra (%) 
detected by LC-MS/MS from three different methodological approaches targeting A) the enrichment of M. suis 
cells, B) the soluble and C) the insoluble fraction (right x-axis). 
Using this sample preparation approach we succeed to analyze the proteome profile of 
M. suis during acute IAP at day 8 p. infection. By this 404 of 795 M. suis proteins could be 
identified which correspond to 52% of all encoded proteins. It is noteworthy that this 
identification ratio is in accordance with GeLC-MS/MS protein identification levels for other 
cultivable mycoplasmas (Wasinger et al. 2000; Jaffe et al. 2004; Pendarvis et al. 2014). In 
this approaches bacterial cells can be purified from pure cultures. 
Unfortunately, our approach did not worked to analyze the M. suis specific expression 
pattern in the early phase of infection. This is especially due to the fact that in this infection 
period only low numbers of bacteria can be found in the blood. Therefore, the ratio between 
the expressed M. suis proteins and the expressed host proteins is in disfavor to the M. suis 
proteins. 
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So, only nine M. suis proteins (eight from the M. suis enriched fraction, one from the buffer 
soluble fraction, and zero from the buffer-insoluble fraction) could be detected. These 
proteins are highly abundant M. suis proteins such as DNA directed RNA polymerase subunit 
beta (detected in two fractions), elongation factor Tu and G, chaperone protein DnaK, 
glyceraldehy-3-P dehydrogenase, 2,3-bisphosphoglycerate-independent phospho-glycerate 
mutase, pyruvate kinase and MgpA-like protein. These results demonstrate that the modern 
and sophisticated proteome analysis suffers from limitations, i.e. the significant amounts of 
S. scrofa proteins overwhelm M. suis proteins and thereby their identification.  
To overcome the detection limit of the system an M. suis-specific enrichment should be 
established in future. One possibility is the inclusion of an M. suis enrichment step into the 
described protocol (Dietz et al. 2015). One possible option for the enrichment could be the 
use of beads coated with monoclonal antibodies directed against M. suis surface antigens 
(e.g. pluriBeads; pluriselect, Leipzig, Germany).  
Nevertheless, the pig related dataset enables the quantitative identification of host proteins 
also during the early phase of infection and is a reliable and worthwhile basis to get further 
information about the misdirected host immune response in IAP. 
 
Comprehensive proteome results were used to unravel host pathogen interactions and host 
adaptation of M. suis. Our study proved that glycolysis seems to be the major energy 
generating pathway in M. suis. However, this leads to a life-threatening hypoglycemia and to 
a lactate acidosis (Heinritzi et al. 1991c; Hoelzle et al. 2014). After glycolysis, the lactate 
dehydrogenase catalyzes the formation of lactate out of pyruvate. Lactate is thought to be 
exported out of the M. suis cytoplasm into the blood which leads to a drop of the blood pH 
from 7.4 to 7.1, which indicates a metabolic acidosis (Heinritzi et al. 1990c).  
So far, it is unclear how M. suis generates energy during the intracellular lifestyle in the 
RBCs. Nevertheless, we suggest that the hexose-6-phosphate-transporter is involved in the 
uptake of phosphorylated glucose during the intracellular lifestyle in premature as well as in 
mature RBCs (Figure 8). In Listeria monocytogenes the loss of a hexose-phosphate-
transport protein results in impaired intracytosolic proliferation and attenuated virulence in 
mice (Chico-Calero et al. 2002). Future experiments have to clarify the importance of the 
hexose-6-phosphate-transporter in M. suis.  
Interestingly, our PATRIC analysis revealed that the annotated cobalt ABC-transporter 
seems to be an energy-coupling factor (ECF)–transporter (Figure 8). The most significant 
difference between ABC- and ECF-transporters is that ECF-transporters do not have extra-
cytoplasmic binding proteins. Instead, substrate binding is carried out by one (S component) 
of the two membrane localized proteins (S and T components; Song et al. 2013). Transport 
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is energized by two ATP-binding cassette-containing proteins (ABC proteins; Song et al. 
2013). However, the associated genes of the mentioned M. suis ECF-transporter consist of 
one T and two ABC components and do not have adjacent candidate S-component genes. 
Group II ECF-transports are accompanied by different candidate S-component genes 
scattered randomly throughout the genome (Song et al. 2013). Some genomes encode more 
than 12 different S-component genes but only one or two copies of the energy-coupling ABC-
T module (Song et al. 2013). The vast majority of these candidate S components probably 
act on new substrates. Common substrates are e.g. nickel, cobalt, biotin, 
methylthioadenosine, riboflavin, folate, pantothenate, thiamine, thiazole, niacin, tryptophan, 
pyridoxine, lipoate as well as the precursors of cobalamin, thiamine, methionine and 
queuosine (Song et al. 2013). We suggest that the modularity of the group II ECF-transporter 
also contributes to a broad substrate spectrum in M. suis, since only one S component for 
the uptake of folate could be identified by PATRIC annotations. 
Information about the iron-uptake in mycoplasmas is still limited. Comparative genome 
analysis by PATRIC revealed that Ureaplasma parvum represents a comparable genome 
locus for iron uptake when compared to M. suis (unpublished data). The fact that a 
siderophore uptake system is encoded and expressed during infection suggests that M. suis 
is capable of synthesizing siderophores (Figure 8).  
Information about proteins involved in nutrient uptake by M. suis from the host-environment 
could be one key in the establishment of an in vitro cultivation system. Particularly the 
targeted supplementation of the media with individual nutrients can play a key role in the 
establishment of an in vitro M. suis culture system in the future. 
Based on the missing cell wall, mycoplasmas have a natural resistance to ß-lactam 
antibiotics. Moreover, resistance against macrolides could be enhanced by efflux-pumps 
which were detected during the acute phase of infection. This resistance against macrolides 
could be demonstrated in other Mollicutes (Figure 8; Raherison et al. 2002; Szczepanowski 
et al. 2004). The presence of a multi-drug resistance efflux-pump might relieve initial survival 
of the bacterium and facilitates the opportunity to acquire other resistance genes 
(Szczepanowski et al. 2004). 
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The M. suis genome encodes a high portion of hypothetical proteins (65.9%), considerably 
exceeding the numbers found in other mycoplasma species e.g. 20.2% in M. gallisepticum 
and 22,8% in M. fermentans (Papazisi et al. 2003; Rechnitzer et al. 2011; Felder et al. 2012). 
In the present study 188 of the 533 M. suis KI_3806 ORFs (35.3%) encoding hypothetical 
proteins could be confirmed as expressed during acute infection. In contrast, the expression 
of only 6.0% (32/533) of these genes could be verified by the proteome approach of Felder 
and co-workers (2012). This is probably due to the fact, that we used both an improved 
M. suis enrichment protocol and a faster and more sensitive mass spectrometer (Orbitrap 
Elite). Based on this fact, we could prove the expression of a great proportion of these 
putative hypothetical proteins during the acute IAP. Therefore, we can suggest that they 
carry out significant functions during acute infection and the life cycle of M. suis. Probably, 
they encode unique proteins responsible for the high degree of host adaptation to the hostile 
environment of the porcine blood system (Felder et al. 2012). Therefore, future approaches 
will deal with the recombinant expression as well as the structural and functional 
characterization of these proteins. Hypothetical proteins which were predicted as potential 
membrane proteins in this study will thereby be the first choice. 
 
Lipoproteins are considered as the most important pathogenic elements in mycoplasmas 
(Zuo et al. 2009). To date, it is known that mycoplasma lipoproteins play a key role in 
infection and are able to adjust the host immune system and are necessary during the 
ignition process (Zuo et al. 2009). Moreover, they are pro-inflammatory eliciting innate as 
well as adaptive immune responses and have a role in virulence-associated functions, like 
invasion, colonization, and evasion of host defense (Zuo et al. 2009; Browning et al. 2011). 
In HMs it was possible to predict 15 lipoproteins encoded by the genome of M. haemocanis 
and 17 of M. haemofelis including some hypothetical proteins (do Nascimento et al. 2012). 
For M. parvum three lipoproteins were predicted (do Nascimento et al. 2014). In M. suis we 
found also three lipoproteins using the LipoP 1.0 algorithm. These three lipoproteins were 
found to be expressed in M. suis during acute IAP (Msui06740, Msui01480 and Msui00920). 
Interestingly, one of these hypothetical proteins seems to be an ABC transporter permease. 
 
M. suis is the only HM which has been investigated by proteomics until today. Moreover, to 
our knowledge, this study is the most successful and comprehensive proteome report. 
Besides the M. suis proteome the complete protein dataset (M. suis, S. scrofa) enables the 
quantitative identification the M. suis induced and/ or influenced gene expression of S. scrofa 
proteins during different time points of acute IAP containing low and high bacterial loads 
(unpublished data). Based on these datasets further evaluations could provide new insights 
into the pathogen-related physiology of the host during acute IAP infection. 
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7 CONCLUSION AND FUTURE CHALLENGES  
M. suis is worldwide distributed in pig industry causing acute and chronic infections. The 
acute disease called IAP is well known since more than 80 years. However, clinically 
asymptomatic infected pigs constitute the major epidemiological problem and lead to high 
economic losses in swine production. Furthermore, the lack of a M. suis in vitro cultivation 
system hinders the investigation of the pathobiology of this organism. 
Despite all these limitations, the work of the present PhD thesis was successful in 
i) establishing a pig infection model for the investigation of chronic M. suis infections, 
ii) identifying blood-independent transmission pathways of M. suis, and iii) deepening our 
knowledge on the gene expression of M. suis during acute disease by using proteomics. 
The novel chronic infection model enables the analysis of M. suis infections in the porcine 
host during considerably longer investigation periods. Compared to the existing infection 
model, the typical cyclic course of anemia can be observed in this model. Therefore, it is 
possible to investigate anemia attacks containing high bacterial loads as well as clinically 
inapparent infection phases characterized by low bacteremia. In conclusion, both infection 
models are necessary and very promising for further studies on pathogenic differences 
between chronic and acute M. suis infections.  
In this thesis, both infection models were used to determine potential blood-independent 
transmission pathways of M. suis. For this, feces, urine, air and dust as well as nasal, vaginal 
and saliva secretions were screened for M. suis DNA by Rt-PCR. It was possible to detect 
M. suis in secretions (nasal, vaginal and saliva) and RBC-free urine. Against this, M. suis 
was neither detected in feces nor in air samples. Results gained from these experiments 
indicate that M. suis transmission besides blood or arthropod-dependent pathways during 
chronic and acute IAP are also of epidemiological significance. Additionally, it should be 
queried whether M. suis transmission via oral ingestion of vaginal secretions during 
parturition is possible. To exclude the transmission during birth piglets from M. suis-infected 
sows and born by C-section should be investigated in future. Our results proof for the first 
time blood-independent M. suis transmission pathways, extend knowledge about M. suis 
epidemiology and will help to develop strategies to disrupt infection chains of M. suis.  
As aforementioned information on the pathobiology of M. suis is rather limited due to different 
reasons. Nevertheless, novel high-throughput laboratory approaches (omics) are 
predestinated in such situations. To deepen our knowledge about M. suis gene expression 
during acute infections we used modern and sophisticated proteome analysis. For this, a 
novel enrichment method of M. suis membrane proteins was established. This method 
enabled an improved resolution of the protein expression profile of M. suis and thereby 
deeper insights into the pathogenesis of the organism. Moreover, in this work more than 50% 
of the encoded M. suis proteins were successfully identified as expressed during the acute 
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phase of infection. This identification ratio is in accordance with GeLC-MS/MS protein 
identification levels for other cultivable mycoplasmas. 
In addition, it was possible to prove the expression of 180 so-called hypothetical proteins. 
Therefore, it is rather probable that these proteins are important and responsible for the 
unique life style of M. suis. Thus, future studies will be performed to unravel their functions, 
e.g. nutrient transport (as substrate binding-components in ECF-transporter system), host 
adaptation mechanisms or immune evasion.  
Based on the new M. suis enrichment, it was possible to identify several expressed proteins 
involved in transport of nutrients. Our data prove that nutrients like glucose, hexose-6-
phosphate, spermidine, putrescine, phosphate, amino acids, magnesium, potassium, sodium 
and iron are taken up from the host environment by M. suis. Moreover, information on 
M. suis proteins involved in transport mechanisms should also be helpful in the 
establishment of an in vitro cultivation system in future. Particularly, the supplementation of 
individual nutrients can play a key role in finding a suitable medium to support M. suis growth 
in vitro.  
In conclusion, the established enrichment strategy of membrane proteins combined with 
enhanced proteome analysis provides excellent results during the acute phase of the M. suis 
infection associated with high bacterial loads in the blood. Against that, it was not possible to 
identify a comparable M. suis proteome during low bacteremia due to the high amount of pig 
proteins in relation to low numbers of M. suis-specific proteins. We found five proteins 
representing a phosphotranspherase system as well as several well-known chaperons. 
However, the analysis of differentially expressed proteins of S. scrofa during the early 
infection will give deeper insights into the (immune) response of the host. Besides 
immunology, nobody has examined the ongoing molecular processes in the host during 
M. suis infection. The proteome dataset acquired from the pig in this work firstly enables 
these studies and can help to unravel infection-relevant process in the host and provides 
further insights into the initiation of the misguided immune response. 
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